![]() |
市場調查報告書
商品編碼
1827727
2025年全球心電圖設備市場報告ECG Devices Global Market Report 2025 |
近年來,心電圖設備市場規模快速擴張,從2024年的65.6億美元成長到2025年的73.9億美元,複合年成長率達12.6%。這段時期的成長動力源自於心血管疾病發病率的上升、人口老化、診斷和監測需求的增加、醫療基礎設施的建設、遠端醫療和遠端監測以及居家醫療等因素。
預計未來幾年心電圖設備市場規模將快速成長,到2029年將達到122.2億美元,複合年成長率為13.4%。預測期內的成長可歸因於心律不整早期檢測的增加、連線健診醫療和治療、對互聯健康生態系統日益成長的需求、新興市場的擴張、非侵入性心臟監測以及疫情後對醫療保健的關注。預測期內的主要趨勢包括可攜式和穿戴式心電圖設備、遠端醫療和遠距會診中的心電圖、人工智慧和機器學習的整合、技術進步以及醫療物聯網的普及。
心電圖 (ECG) 是一種診斷程序,它記錄心臟電訊號,以監測心臟功能並檢測潛在的心血管健康問題。這些設備在診斷應用中發揮重要作用。
心電圖設備市場主要包含兩大產品類型:監測心電圖系統和診斷心電圖系統。監測心電圖系統旨在記錄心臟電訊號,並用於評估各種心臟狀況。這些系統提供多種導極類型,包括單導聯心電圖、3 至 6 導程心電圖和 12 導程心電圖,並採用多種技術,包括可攜式和無線心電圖系統。監測心電圖系統廣泛應用於各個領域,包括醫院、居家照護機構和其他醫療保健環境。
2025年春季美國關稅大幅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰進一步加劇了形勢,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供心電圖設備市場統計數據,例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的心電圖設備細分市場、市場趨勢和商業機會,以及您在心電圖設備行業取得成功所需的數據。本心電圖設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
我們對該市場未來五年13.4%的成長率預測與先前保持不變。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自荷蘭和新加坡等主要地區的高解析度類比前端晶片和觸控螢幕徵收關稅直接影響美國,從而導致心臟診斷能力下降和設備採購成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,影響也將更加廣泛。
心血管疾病盛行率的上升預計將在未來幾年推動心電圖設備市場的成長。心血管疾病是全球最常見的健康問題之一,也是導致死亡的主要原因。心電圖 (ECG 或 EKG) 透過測量心臟產生的電訊號來檢測各種心臟狀況。電極連接到胸部以記錄這些負責心率的電訊號。例如,2024 年 5 月,美國政府機構疾病管制與預防中心 (CDC) 報告稱,2022 年心臟病將導致美國702,880 人死亡,佔死亡人數的五分之一。因此,高血壓心臟疾病、中風、周邊動脈疾病和缺血性心臟疾病(IHD) 等心血管疾病盛行率的不斷上升正在推動預測期內心電圖設備市場的成長。
預計未來幾年,醫療保健支出的增加將推動心電圖設備市場的成長。醫療保健支出的增加通常會帶來醫學研發資金的增加,從而促進心電圖設備在初級保健機構(尤其是在發展中地區和國家)的廣泛應用。例如,2023年5月,英國國家統計局(政府機構)報告稱,英國的醫療保健支出將達到約3548.8億美元(2830億英鎊),較2021年名義增加0.7%。因此,醫療保健支出的增加預計將促進心電圖設備市場的擴張。
技術進步已成為心電圖設備市場的關鍵趨勢,主要企業專注於開發尖端解決方案以保持其市場地位。 2022 年 1 月,總部位於荷蘭的企業集團荷蘭皇家飛利浦公司推出了一種家用 12 導程心電圖 (ECG) 解決方案,旨在分散臨床試驗。這種創新的解決方案允許臨床試驗參與者使用 PCA 500 ECG 貼片資料記錄技術在家中記錄與中心 ECG 相當的高品質資料。此解決方案的體戴式貼片可實現合規的 12 導聯 ECG 和近乎即時、高度安全的資料傳輸,而無需頻繁的現場訪問、臨床實驗技術人員或訪問護理師。預計這項技術進步將促進 ECG 設備市場的成長。
心電圖設備市場的主要企業正策略性地專注於推出心臟監測貼片,以此作為競爭優勢。這些醫療設備也稱為心臟心臟事件記錄器或心臟心電圖監測,可長時間持續監測患者的心臟活動。例如,2022 年 8 月,瑞士醫療設備製造商 SmartCardia SA 宣佈在印度市場推出 7 導程心臟監測貼片 7L。這種創新的貼片將醫療穿戴式技術與人工智慧 (AI) 相結合,透過遠端監控提供預測性和個人化的患者見解。 7L 貼片由 SmartCardia 的 AI 平台追蹤,並由委員會認證的心臟病專家和循環系統進行解讀,可即時檢測關鍵心律失常事件,其準確度可與循環系統相媲美。
2024年5月,日本醫療設備製造商歐姆龍醫療(OMRON Healthcare)與AliveCor合作,推出一款用於早期發現和管理心臟病的可攜式心電圖設備,旨在改善印度的心血管健康監測。這家總部位於美國的醫療設備公司AliveCor允許用戶透過智慧型手機應用程式方便地記錄和監測心臟活動。
心電圖設備市場的主要企業包括 GE Healthcare Technologies Inc.、Koninklijke Philips NV、Spacelabs Healthcare Inc.、CardioNet LLC、Schiller AG、Nihon Kohden Corporation、Medtronic plc、OSI Systems Inc.、深圳生物醫療電子有限公司、Hill-Rom Holdings Inc.、BPL Medical Technologies Private Limited、MortNA Technologies PrivateS. Co.Ltd.、Cardiac Science Corporation、Midmark Corporation、Omron Healthcare Inc.、Abbott Laboratories、AliveCor Inc.、Compumedics Limited、BioTelemetry Inc.、Welch Allyn Inc.、Natus Medical Incorporated、Innomed Medical & Develoshi and Manufacturing Ltd.、BIoTronik Ltd. Inc.Ltd.、Spacelabs Healthcare、Medical International Limited、深圳生物醫療電子有限公司等。
2024年心電圖設備市場最大的地區是北美。預計亞太地區將成為預測期內心電圖設備市場成長最快的地區。心電圖設備市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
心電圖設備市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。
心電圖設備市場包括監視器、電極、擴大機和導聯線的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商向其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
An Electrocardiogram (ECG) is a diagnostic procedure that involves recording the heart's electrical signals to monitor its function and detect potential cardiovascular health issues. These devices play a crucial role in diagnostic applications.
The ECG devices market primarily consists of two main product types such as monitoring ECG systems and diagnostic ECG systems. Monitoring ECG systems are designed to record the heart's electrical signals, allowing for the assessment of various cardiac conditions. These systems come in different lead types, including single-lead ECG, 3-6 lead ECG, and 12-Lead ECG, and utilize diverse technologies such as portable and wireless ECG systems. The implementation of monitoring ECG systems is widespread across various sectors, including hospitals, home care settings, and other healthcare environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The ECG devices market research report is one of a series of new reports from The Business Research Company that provides ECG devices market statistics, including ECG devices industry global market size, regional shares, competitors with a ECG devices market share, detailed ECG devices market segments, market trends and opportunities, and any further data you may need to thrive in the ECG devices industry. This ECG devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ecg devices market size has grown rapidly in recent years. It will grow from $6.56 billion in 2024 to $7.39 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, diagnostic and monitoring needs, healthcare infrastructure growth, telemedicine and remote monitoring, and home-based healthcare.
The ecg devices market size is expected to see rapid growth in the next few years. It will grow to $12.22 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing early detection of cardiac arrhythmias, personalized medicine and treatment, growing need for connected health ecosystem, emerging market expansion, non-invasive cardiac monitoring, and post-pandemic healthcare focus. Major trends in the forecast period include portable and wearable ecg devices, ecg in telehealth and remote consultations, ai and machine learning integration, technological advancements, and healthcare iot adoption.
The forecast of 13.4% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-resolution analog front-end chips and touchscreen displays, sourced from key regions such as the Netherlands and Singapore, which could lead to reduced cardiac diagnostic capabilities and higher equipment procurement expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of cardiovascular diseases is anticipated to drive the growth of the ECG devices market in the coming years. Cardiovascular disease is one of the most prevalent health issues and is the leading cause of death worldwide. An electrocardiogram (ECG or EKG) is used to detect various cardiac conditions by measuring the electrical signals generated by the heart. Electrodes are placed on the chest to record these electrical signals, which are responsible for the heartbeat. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that heart disease accounted for 702,880 deaths in the United States in 2022, representing 1 in every 5 deaths. Therefore, the increasing prevalence of cardiovascular diseases, including hypertensive heart disease, stroke, peripheral artery diseases, and ischemic heart disease (IHD), is driving the growth of the ECG devices market during the forecast period.
The rise in healthcare expenditure is anticipated to drive the growth of the ECG devices market in the future. Higher healthcare spending often leads to increased funding for medical research and development, facilitating the widespread adoption of ECG devices in primary healthcare settings, especially in developing regions and countries. For example, in May 2023, the Office for National Statistics, a UK-based government department, reported that healthcare expenditure in the UK amounted to approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% from 2021. Therefore, the growing healthcare expenditure is expected to contribute to the expansion of the ECG devices market.
Technological advancements emerge as a significant trend in the ECG devices market, with major companies focusing on developing cutting-edge solutions to maintain their market positions. In January 2022, Royal Philips, a Netherlands-based conglomerate corporation, introduced an at-home 12-lead electrocardiogram (ECG) solution designed for use in decentralized clinical trials. This innovative solution enables clinical trial participants to record high-quality data at home, comparable to site-based ECGs, utilizing PCA 500 ECG patch data recording technology. The solution's body-worn patch allows compliant 12-lead ECG implementation and near-real-time, highly secure data transfer without the need for frequent site visits, onsite technicians, or home nurses. This technological advancement is anticipated to contribute to the growth of the ECG devices market.
Major players in the ECG devices market are strategically emphasizing the introduction of cardiac monitoring patches as a key competitive advantage. Also known as cardiac event monitors or cardiac Holter monitors, these medical devices offer continuous monitoring of a patient's heart activity over an extended duration. For instance, in August 2022, SmartCardia SA, a Swiss medical equipment manufacturer, unveiled its 7L patch, a 7-lead cardiac monitoring patch introduced in the Indian market. This innovative patch integrates medical wearable technology with artificial intelligence (AI) to deliver predictive and personalized patient insights through remote monitoring. Tracked by SmartCardia's AI platform and interpreted by certified cardiac technicians and cardiologists, the 7L patch achieves real-time detection of significant arrhythmia events at a level of accuracy comparable to that of cardiologists.
In May 2024, OMRON Healthcare, a Japan-based medical equipment firm, partnered with AliveCor. This collaboration aims to improve cardiovascular health monitoring in India by introducing portable ECG devices designed for the early detection and management of heart diseases. AliveCor, a US-based medical device company, enables users to conveniently record and monitor their heart activity through a smartphone app.
Major companies operating in the ECG devices market include GE Healthcare Technologies Inc., Koninklijke Philips N.V., Spacelabs Healthcare Inc., CardioNet LLC, Schiller AG, Nihon Kohden Corporation, Medtronic plc, OSI Systems Inc., Shenzhen Bio-Medical Electronics Co. Ltd., Hill-Rom Holdings Inc., BPL Medical Technologies Private Limited, Mortara Instrument Inc., General Electric Company, Opto Circuits Limited, Bionet Co. Ltd., Cardiac Science Corporation, Midmark Corporation, Omron Healthcare Inc., Abbott Laboratories, AliveCor Inc., Compumedics Limited, BioTelemetry Inc., Welch Allyn Inc., Natus Medical Incorporated, Innomed Medical Developing and Manufacturing Ltd., Biotronik SE & Co. KG, Fukuda Denshi Co. Ltd., Spacelabs Healthcare, Medical International Limited, Shenzhen Bio-Medical Electronics Co. Ltd.
North America was the largest region in the ECG devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the ECG devices market during the forecast period. The regions covered in the ECG devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the ECG devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The ECG devices market consists of sales of monitors, electrodes, amplifiers, and leads. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
ECG Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ecg devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ecg devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ecg devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.